Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PC-SOD in Myocardial Reperfusion Injury
NCT03995732Phase 2Unknown
- Sponsor
- Beijing Tide Pharmaceutical Co., Ltd.
- Start
- Jun 2019
- Primary completion
- Oct 2020
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of lecithinized superoxide dismutase in myocardial reperfusion injury, sponsored by Beijing Tide Pharmaceutical Co., Ltd.. Status: unknown.
02
Drugs
lecithinized superoxide dismutase
03
Conditions
myocardial reperfusion injury
Beyond the preview
Go deeper on NCT03995732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03995732.